XML 15 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Cash flows from operating activities:    
Net income $ 71,848 $ 28,559
Adjustments to reconcile net income to net cash provided by operating activities:    
Accretion of deferred acquisition fees and origination costs 0 651
Net interest income accretion on fair value receivables 97,462 100,676
Depreciation and amortization 1,207 1,254
Amortization of deferred financing costs 5,860 5,360
Mark to finance receivables measured at fair value (15,283) 4,417
Provision for credit losses (23,400) (1,590)
Stock-based compensation expense 2,966 1,265
Purchases of finance receivables held-for-sale 0 (23,700)
Sale of finance receivables held-for-sale 0 23,513
Changes in assets and liabilities:    
Accrued interest receivable 1,493 2,087
Deferred tax assets, net 5,005 3,146
Other assets 5,252 8,629
Accounts payable and accrued expenses 12,334 8,809
Net cash provided by operating activities 164,744 163,076
Cash flows from investing activities:    
Payments received on finance receivables held for investment 109,894 198,366
Purchases of finance receivables measured at fair value (1,311,735) (795,457)
Payments received on finance receivables at fair value 635,401 546,897
Change in repossessions held in inventory 1,694 1,567
Purchase of furniture and equipment (1,778) (1,547)
Net cash used in investing activities (566,524) (50,174)
Cash flows from financing activities:    
Proceeds from issuance of securitization trust debt 1,104,000 761,545
Proceeds from issuance of subordinated renewable notes 4,004 7,416
Payments on subordinated renewable notes (3,214) (1,277)
Net proceeds from (repayments of) warehouse lines of credit 139,477 (22,089)
Net Proceeds from (repayment of) residual interest financing debt (4,311) 39,705
Repayment of securitization trust debt (804,774) (861,045)
Payment of financing costs (10,407) (5,752)
Purchase of common stock (41,535) (3,959)
Exercise of options and warrants 14,698 2,167
Net cash provided by (used in) financing activities 397,938 (83,289)
Increase (decrease) in cash and cash equivalents (3,842) 29,613
Cash and restricted cash at beginning of period 176,548 144,152
Cash and restricted cash at end of period 172,706 173,765
Supplemental disclosure of cash flow information:    
Interest 51,300 53,931
Income taxes $ 13,977 $ 8,997